Prospective_JJ Survey_NN of_IN beta-Lactamases_NNS Produced_JJ by_IN Ceftazidime-_NP Resistant_NP Pseudomonas_NP aeruginosa_NP Isolated_JJ in_IN a_DT French_JJ Hospital_NN in_IN 2000_CD In_IN 2000_CD ,_, at_IN the_DT Universite_NP d'Auvergne_NP teaching_NN hospital_NN in_IN Clermont-Ferrand_NP ,_, France_NP ,_, 44_CD (_( 6.2_CD %_NN )_) strains_NNS of_IN Pseudomonas_NP aeruginosa_NP were_VBD found_VBN to_TO be_VB resistant_JJ to_TO ceftazidime_NN ._SENT After_IN genotyping_NN ,_, 34_CD strains_NNS were_VBD selected_VBN ._SENT Nine_NP had_VBD an_DT additional_JJ beta-lactamase_NN :_: OXA-21_NP (_( n_NN =_SYM 6_CD )_) ,_, PSE-1_NP (_( CARB-2_NP )_) (_( n_NN =_SYM 2_CD )_) ,_, or_CC PER-1_NP (_( n_NN =_SYM 1_CD )_) ._SENT Ceftazidime_NP resistance_NN was_VBD related_VBN solely_RB to_TO the_DT overproduction_NN of_IN the_DT cephalosporinase_NN in_IN 30_CD strains_NNS ._SENT Sequencing_VBG of_IN five_CD blaAmpC_NN genes_NNS encoding_VBG cephalosporinases_NNS with_IN different_JJ pIs_NNS showed_VBD 99_CD %_NN identity_NN with_IN the_DT ampC_NN gene_NN of_IN P._NP aeruginosa_NP PAO1_NP ._SENT Resistance_NN to_TO extended-spectrum_NN cephalosporins_NNS in_IN Pseudomonas_NP aeruginosa_NP is_VBZ associated_VBN in_IN most_JJS cases_NNS with_IN the_DT overproduction_NN of_IN a_DT naturally_RB produced_VBN cephalosporinase_NN ._SENT Derepression_NN of_IN this_DT AmpC_NP beta-lactamase_NN affects_VBZ all_DT beta-lactams_NNS to_TO various_JJ extents_NNS ,_, which_WDT may_MD lead_VB to_TO the_DT misdetection_NN of_IN other_JJ acquired_VBN beta-lactamases_NNS ._SENT Enzymes_NNS hydrolyzing_VBG extended-spectrum_NN cephalosporins_NNS of_IN Ambler_NP classes_NNS A_NP ,_, B_NP ,_, and_CC D_NP have_VBP been_VBN reported_VBN in_IN P._NP aeruginosa_NP ._SENT Among_IN the_DT extended-spectrum_NN beta-lactamases_NNS (_( ESBLs_NP )_) of_IN class_NN A_NP ,_, TEM-4_NP ,_, TEM-24_NP ,_, TEM-42_NP ,_, PER-1_NP ,_, SHV-2a_NP ,_, VEB-1_NP ,_, and_CC GES-2_NP have_VBP been_VBN encountered_VBN ._SENT Class_NP B_NP enzymes_NNS ,_, IMP-1_NP ,_, VIM-1_NP ,_, VIM-2_NP ,_, and_CC VIM-related_JJ enzymes_NNS ,_, hydrolyze_VB carbapenems_NNS in_IN addition_NN to_TO extended-spectrum_NN cephalosporins_NNS ._SENT The_DT extended-spectrum_NN class_NN D_NP enzymes_NNS are_VBP OXA-2_JJ derivatives_NNS (_( OXA-15_NP and_CC OXA-32_NP )_) ,_, OXA-10_NP derivatives_NNS (_( OXA-11_NP ,_, OXA-14_NP ,_, OXA-16_NP ,_, OXA-17_NP ,_, OXA-19_NP ,_, and_CC OXA-28_NP )_) ,_, and_CC OXA-18_NP ._SENT Other_JJ mechanisms_NNS implicated_VBN in_IN resistance_NN to_TO beta-lactams_NNS in_IN P._NP aeruginosa_NP are_VBP impermeability_NN of_IN the_DT outer_JJ membrane_NN and_CC increased_VBD efflux_NN The_DT aim_NN of_IN this_DT study_NN was_VBD to_TO characterize_VB the_DT beta-lactamases_NNS produced_VBN by_IN ceftazidime-resistant_JJ P._NP aeruginosa_NP isolates_VBZ ._SENT Of_IN the_DT 713_CD nonduplicate_NN P._NP aeruginosa_NP strains_NNS isolated_VBN from_IN the_DT Universite_NP d'Auvergne_NP teaching_NN hospital_NN in_IN Clermont-Ferrand_NP ,_, France_NP ,_, between_IN 1_CD January_NP and_CC 30_CD September_NP 2000_CD ,_, 44_CD (_( 6.2_CD %_NN )_) were_VBD resistant_JJ to_TO ceftazidime_NN ,_, as_RB determined_VBN by_IN the_DT disk_NN diffusion_NN method_NN on_IN Mueller-Hinton_NP agar_NN according_VBG to_TO the_DT recommendations_NNS of_IN the_DT Antibiogram_NN Committee_NN of_IN the_DT French_NP Society_NP for_IN Microbiology_NP (_( zone_NN diameter_NN ,_, <15_mm; 8_CD mug/ml_NN )_) ,_, and_CC of_IN these_DT ,_, three_CD were_VBD resistant_JJ to_TO meropenem_VB (_( MICs_NP ,_, >8_NN mug/ml_NN )_) ._SENT Cephalosporinase_NN inhibition_NN ,_, evaluated_VBN by_IN the_DT disk_NN diffusion_NN method_NN on_IN Mueller-Hinton_NP agar_NN containing_VBG cloxacillin_NN at_IN 250_CD or_CC 500_CD mug/ml_NN ,_, was_VBD considered_VBN significant_JJ when_WRB the_DT ceftazidime_JJ zone_NN diameter_NN increased_VBN by_IN >10_JJ mm_NN ._SENT P._NP aeruginosa_NP PAO1_NP was_VBD used_VBN as_IN the_DT reference_NN strain_NN ._SENT For_IN 25_CD strains_NNS which_WDT did_VBD not_RB have_VB pI_NN values_NNS that_WDT might_MD correspond_VB to_TO those_DT for_IN an_DT additional_JJ beta-lactamase_NN ,_, ceftazidime_NN activity_NN was_VBD partially_RB restored_VBN by_IN cloxacillin_NN at_IN 250_CD mug/ml_NN (_( n_NN =_SYM 15_CD )_) or_CC only_RB by_IN cloxacillin_NN at_IN 500_CD mug/ml_NN (_( n_NN =_SYM 10_CD )_) ._SENT For_IN these_DT 25_CD strains_NNS without_IN an_DT additional_JJ beta-lactamase_NN ,_, the_DT level_NN of_IN production_NN of_IN the_DT AmpC_NP enzymes_NNS was_VBD measured_VBN by_IN determination_NN of_IN their_PP$ specific_JJ beta-lactamase_NN activities_NNS ._SENT Cultures_NNS were_VBD grown_VBN overnight_RB at_IN 37C_JJ in_IN 3_CD liters_NNS of_IN brain_NN heart_NN infusion_NN (_( Biokar_NP Diagnostics_NP ,_, Beauvais_NP ,_, France_NP )_) ._SENT Bacterial_JJ suspensions_NNS were_VBD disrupted_VBN by_IN sonication_NN and_CC centrifuged_VBD as_RB described_VBN previously_RB ._SENT The_DT supernatants_NNS were_VBD dialyzed_VBN against_IN 3_CD liters_NNS of_IN 100_CD mM_NP NaCl_NP overnight_RB at_IN 4C_JJ ._SENT Then_RB ,_, the_DT specific_JJ beta-lactamase_NN activities_NNS of_IN the_DT crude_NN extracts_VBZ were_VBD determined_VBN by_IN a_DT computerized_JJ microacidimetric_JJ method_NN described_VBD elsewhere_RB with_IN 225_CD mM_NP benzylpenicillin_NN as_IN the_DT substrate_NN ._SENT The_DT total_JJ protein_NN concentration_NN in_IN the_DT enzyme_NN preparation_NN was_VBD estimated_VBN by_IN a_DT protein_NN assay_NN (_( Bio-Rad_NP ,_, Richmond_NP ,_, Calif._NP )_) with_IN bovine_JJ serum_NN albumin_NN (_( Sigma_NP Chemical_NP Co._NP ,_, St._NP Louis_NP ,_, Mo._NP )_) as_IN the_DT standard_NN ._SENT One_CD unit_NN of_IN specific_JJ beta-lactamase_NN activity_NN was_VBD defined_VBN as_IN the_DT amount_NN of_IN enzyme_NN which_WDT hydrolyzes_VBZ 1_CD mumol_NN of_IN benzylpenicillin_NN per_IN min_NP and_CC per_IN mg_NN of_IN protein_NN at_IN 37C_JJ and_CC at_IN pH_NN 7_CD ._SENT For_IN 21_CD strains_NNS the_DT specific_JJ activity_NN was_VBD 100-_CD to_TO 1,000-fold_NN greater_JJR than_IN that_DT of_IN PAO1_NP ,_, with_IN values_NNS ranging_VBG from_IN 124_CD to_TO 15,373_CD mU_NN mg-1_NN ._SENT Variations_NNS in_IN levels_NNS of_IN resistance_NN to_TO ceftazidime_NN were_VBD weakly_RB related_VBN to_TO different_JJ levels_NNS of_IN enzyme_NN overproduction_NN (_( i.e._FW ,_, an_DT MIC_NN of_IN 64_CD mug/ml_NN corresponds_VBZ to_TO specific_JJ activities_NNS of_IN 52_CD mU_NN mg-1_NN for_IN strain_NN 33_CD and_CC 15,373_CD mU_NN mg-1_NN for_IN strain_NN 5_CD )_) ._SENT The_DT ampC_NN genes_NNS of_IN the_DT strains_NNS that_WDT produced_VBD five_CD cephalosporinases_NNS with_IN different_JJ pI_NN values_NNS were_VBD amplified_VBN with_IN primers_NNS AMPC-PAC_NP and_CC AMPC-PAD_NP under_IN the_DT following_VBG conditions_NNS :_: 94C_NN for_IN 5_CD min_NN and_CC then_RB 30_CD cycles_NNS of_IN 94C_NN for_IN 1_CD min_NN ,_, 50C_NN for_IN 3_CD min_NN ,_, and_CC 72C_NP for_IN 3_CD min_NN ,_, with_IN a_DT single_JJ final_JJ extension_NN at_IN 72C_NP for_IN 15_CD min_NN ._SENT The_DT PCR_NP products_NNS were_VBD sequenced_VBN with_IN the_DT primers_NNS AMPC-PAD_NN ,_, AMPC-PAG_NP ,_, AMPC-28_NP ,_, and_CC AMPC-PAB1_NP ._SENT Sequence_NN analysis_NN showed_VBD a_DT low_JJ level_NN of_IN sequence_NN diversity_NN (_( 0.17_CD to_TO 0.75_CD %_NN )_) and_CC 99_CD %_NN nucleotide_NN identity_NN with_IN the_DT ampC_NN gene_NN of_IN P._NP aeruginosa_NP strain_NN PAO1_NP (_( GenBank_NP accession_NN no_RB ._SENT )_) ._SENT Compared_VBN to_TO the_DT PAO1_JJ ampC_NN gene_NN sequence_NN ,_, all_DT ampC_NN genes_NNS encoding_VBG enzymes_NNS with_IN pIs_NNS different_JJ from_IN 8.0_CD harbored_VBD the_DT mutation_NN A866->G_NN ,_, which_WDT led_VBD to_TO the_DT substitution_NN Thr105->Ala_NP ._SENT TABLE_NN 3_CD |_SYM Substitution_NN in_IN blaAmpC_NN genes_NNS according_VBG to_TO the_DT pI_NN value_NN for_IN each_DT cephalosporinase_NN and_CC comparison_NN with_IN the_DT sequence_NN of_IN the_DT blaAmpC_NN gene_NN of_IN P._NP aeruginosa_NP strain_NN PAO1_NP (_( pI_NP 8.0_CD )_) Genes_NPS encoding_VBG enzymes_NNS of_IN pI_NP 8.0_CD +_SYM 8.4_CD and_CC pI_NP 8.4_CD harbored_VBD a_DT mutation_NN at_IN position_NN 1166_CD that_WDT led_VBD to_TO the_DT substitution_NN Val205->Leu_NP ._SENT The_DT ampC_NN gene_NN encoding_VBG the_DT enzyme_NN of_IN pI_NP 7.8_CD harbored_VBD the_DT mutation_NN G789->A_NP ,_, which_WDT led_VBD to_TO the_DT substitution_NN Arg79->Gln_NP ,_, and_CC that_IN encoding_VBG the_DT enzyme_NN of_IN pI_NP 8.6_CD harbored_VBD the_DT mutation_NN T1080->G_NN ,_, which_WDT led_VBD to_TO the_DT substitution_NN Leu176->Arg_NP ._SENT The_DT Arg79->Gln_NP substitution_NN is_VBZ associated_VBN with_IN a_DT change_NN in_IN charges_NNS and_CC may_MD have_VB been_VBN responsible_JJ for_IN the_DT decrease_NN in_IN the_DT pI_NN value_NN from_IN 8.0_CD to_TO 7.8_CD ,_, as_RB reported_VBD previously_RB ._SENT However_RB ,_, enzymes_NNS with_IN identical_JJ pIs_NNS do_VBP not_RB necessarily_RB share_VB identical_JJ amino_NN acid_NN sequences_NNS ,_, and_CC the_DT different_JJ pIs_NNS suggested_VBD that_IN some_DT bands_NNS correspond_VBP to_TO cleaved_VBN derivatives_NNS (_( isoenzymes_NNS )_) of_IN the_DT cephalosporinase_NN ,_, as_RB reported_VBD previously_RB ._SENT For_IN eight_CD of_IN the_DT nine_CD strains_NNS with_IN an_DT additional_JJ beta-lactamase_NN ,_, ceftazidime_NN activity_NN was_VBD restored_VBN only_RB by_IN cloxacillin_NN at_IN 500_CD mug/ml_NN (_( strains_NNS 18_CD to_TO 25_CD )_) ,_, and_CC so_RB ceftazidime_JJ resistance_NN was_VBD very_RB likely_RB due_JJ to_TO hydrolysis_NN by_IN the_DT derepressed_JJ chromosomal_JJ cephalosporinase_NN ._SENT For_IN strain_NN 4_CD the_DT activity_NN of_IN ceftazidime_NN was_VBD not_RB restored_VBN by_IN cloxacillin_NN at_IN 500_CD mug/ml_NN ._SENT Strain_NN 4_CD was_VBD the_DT only_JJ one_CD which_WDT had_VBD a_DT positive_JJ modified_JJ disk_NN synergy_NN test_NN result_NN with_IN ceftazidime_NN and_CC clavulanate_NN ._SENT The_DT genes_NNS of_IN the_DT six_CD beta-lactamases_NNS with_IN a_DT pI_NN of_IN 7.0_CD were_VBD amplified_VBN with_IN OXA-2_JJ primers_NNS (_( primers_NNS OXA-2,3_NP and_CC OXB-2,3_NP )_) ._SENT Nucleotide_NN sequence_NN analysis_NN of_IN the_DT blaOXA_NP PCR_NP products_NNS revealed_VBD a_DT blaOXA-21_JJ sequence_NN with_IN only_RB one_CD silent_JJ mutation_NN (_( T697->C_NP )_) in_IN the_DT genes_NNS of_IN four_CD isolates_NNS compared_VBN to_TO the_DT sequence_NN of_IN blaOXA-21_NN previously_RB reported_VBD for_IN Acinetobacter_NP baumannii_NP (_( EMBL_NP database_NN accession_NN no_RB ._SENT )_) ._SENT The_DT six_CD strains_NNS that_WDT produced_VBD OXA-21_NP had_VBD different_JJ RAPD_JJ patterns_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO our_PP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ report_NN of_IN OXA-21_NP in_IN P._NP aeruginosa_NP ._SENT The_DT blaPSE-1_JJ gene_NN was_VBD detected_VBN in_IN two_CD strains_NNS by_IN PCR_NP with_IN primers_NNS OC1_NP and_CC OC3_NP ,_, and_CC a_DT protein_NN with_IN a_DT pI_NN of_IN 5.7_CD conferred_VBD a_DT very_RB high_JJ level_NN of_IN resistance_NN to_TO ticarcillin_NP (_( MICs_NP ,_, >2,048_NN mug/ml_NN )_) and_CC ticarcillin-clavulanate_NN (_( MICs_NP ,_, 256/1,024_CD mug/ml_NN )_) ._SENT The_DT blaPER-1_JJ gene_NN of_IN the_DT strain_NN producing_VBG the_DT beta-lactamase_NN with_IN a_DT pI_NN of_IN 5.4_CD was_VBD identified_VBN by_IN PCR_NP with_IN primers_NNS PER-A_NP and_CC PER-B_NP and_CC sequencing_NP ._SENT Epidemics_NNS caused_VBN by_IN strains_NNS with_IN this_DT enzyme_NN ,_, previously_RB reported_VBN in_IN Turkey_NP and_CC Italy_NP ,_, are_VBP now_RB observed_VBN in_IN France_NP ._SENT The_DT carbapenem_NN resistance_NN observed_VBD in_IN 15_CD strains_NNS was_VBD not_RB related_VBN to_TO enzymatic_JJ hydrolysis_NN by_IN a_DT carbapenem-hydrolyzing_NN beta-lactamase_NN ._SENT Although_IN several_JJ ESBLs_NNS were_VBD reported_VBN in_IN P._NP aeruginosa_NP ,_, their_PP$ prevalences_NNS were_VBD very_RB low_JJ in_IN our_PP$ study_NN ._SENT 